Aveanna Healthcare Holdings (AVAH) Cash & Equivalents (2021 - 2026)

Aveanna Healthcare Holdings (AVAH) has 6 years of Cash & Equivalents data on file, last reported at $193.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 129.29% year-over-year to $193.3 million; the trailing twelve-month figure through Jan 2026 stood at $193.3 million (up 129.29% YoY), and the FY2026 full-year result was $193.3 million, up 129.29% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $193.3 million, up from $145.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $193.3 million in Q1 2026 and bottomed at $17.4 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $47.7 million (2024), against an average of $62.8 million.
• The widest annual swing landed in 2022, when Cash & Equivalents sank 83.61%; it then jumped 129.29% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $19.2 million in 2022, then jumped by 128.66% to $43.9 million in 2023, then jumped by 91.82% to $84.3 million in 2024, then surged by 73.06% to $145.9 million in 2025, then jumped by 32.49% to $193.3 million in 2026.
• The last three Cash & Equivalents figures came in at $193.3 million (Q1 2026), $145.9 million (Q3 2025), and $100.7 million (Q2 2025), per Business Quant data.

Peer Comparison